1 |
BAUSCH HEALTH IRELAND LIMITED et al v. TARO PHARMACEUTICALS INC. et al |
2:23-cv-02684 |
D.N.J. |
|
|
|
|
2 |
BAUSCH HEALTH IRELAND LIMITED et al v. TARO PHARMACEUTICALS INC. et al |
2:23-cv-02684 |
D.N.J. |
|
|
|
|
3 |
BAUSCH HEALTH IRELAND LIMITED et al v. TARO PHARMACEUTICALS INC. et al |
2:23-cv-02684 |
D.N.J. |
|
|
|
|
4 |
Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al |
1:18-cv-01673 |
D.Del. |
|
|
|
|
5 |
Allergan, Inc. v. Taro Pharmaceuticals, Inc. |
1:17-cv-01048 |
D.Del. |
|
|
|
|
6 |
Delcor Asset Corporation et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-05405 |
S.D.N.Y. |
|
|
|
|
7 |
Delcor Asset Corporation et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-05405 |
S.D.N.Y. |
|
|
|
|
8 |
Allergan, Inc. v. Taro Pharmaceutical Industries Ltd. |
1:17-cv-00663 |
D.Del. |
|
|
|
|
9 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
10 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
11 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
12 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. TARO PHARMACEUTICALS U.S.A., INC. et al |
2:17-cv-00544 |
D.N.J. |
|
|
|
|
13 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. TARO PHARMACEUTICALS U.S.A., INC. et al |
2:17-cv-00544 |
D.N.J. |
|
|
|
|
14 |
ApoPharma Inc. et al v. Taro Pharmaceutical Industries, Ltd. et al |
2:16-cv-00528 |
E.D.Tex. |
|
|
|
|
15 |
ApoPharma Inc. et al v. Taro Pharmaceutical Industries, Ltd. et al |
2:16-cv-00528 |
E.D.Tex. |
|
|
|
|
16 |
Merz Pharmaceuticals, LLC et al v. Taro Pharmaceuticals U.S.A., Inc. et al |
1:15-cv-10168 |
S.D.N.Y. |
|
|
|
|
17 |
Merz Pharmaceuticals, LLC et al v. Taro Pharmaceuticals U.S.A., Inc. et al |
1:15-cv-10168 |
S.D.N.Y. |
|
|
|
|
18 |
Salix Pharmaceuticals, Inc et al v. Taro Pharmaceutical U.S.A., Inc. et al |
1:15-cv-07980 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
19 |
Salix Pharmaceuticals, Inc et al v. Taro Pharmaceutical U.S.A., Inc. et al |
1:15-cv-07980 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
20 |
HORIZON PHARMA IRELAND LIMITED et al v.TARO PHARMACEUTICALS USA, INC. et al |
1:15-cv-06135 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
21 |
HORIZON PHARMA IRELAND LIMITED et al v.TARO PHARMACEUTICALS USA, INC. et al |
1:15-cv-06135 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
22 |
HORIZON PHARMA IRELAND LIMITED et al v.TARO PHARMACEUTICALS USA, INC. et al |
1:15-cv-06135 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
23 |
HORIZON PHARMA IRELAND LIMITED et al v. TARO PHARMACEUTICALS USA, INC. et al |
1:15-cv-05021 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
24 |
HORIZON PHARMA IRELAND LIMITED et al v. TARO PHARMACEUTICALS USA, INC. et al |
1:15-cv-05021 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
25 |
HORIZON PHARMA IRELAND LIMITED et al v. TARO PHARMACEUTICALS USA, INC. et al |
1:15-cv-05021 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
26 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. TARO PHARMACEUTICALS U.S.A., INC. et al |
2:14-cv-05079 |
D.N.J. |
|
|
|
|
27 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. TARO PHARMACEUTICALS U.S.A., INC. et al |
2:14-cv-05079 |
D.N.J. |
|
|
|
|
28 |
Medicis Pharmaceutical Corporation v. Taro Pharmaceutical U.S.A., Inc. et al |
1:10-cv-03549 |
S.D.N.Y. |
|
|
|
|
29 |
SCHERING CORPORATION v. TARO PHARMACEUTICAL |
2:01-cv-03531 |
D.N.J. |
|
|
|
|